Loading...
•
Dec 31, 2025
NRC Q4 2025 Earnings Report
NRC Health reported its fourth quarter 2025 financial results, showing an increase in total recurring contract value and cash flow from operations.
Key Takeaways
NRC Health concluded Q4 2025 with strong financial performance, driven by disciplined execution and customer trust. The company reported a 2% quarter-over-quarter increase in total revenue to $35.2 million and a significant 13% year-over-year increase in cash flow from operations to $7.2 million. Total Recurring Contract Value (TRCV) grew 8% year-over-year, reaching $144.1 million, marking its fifth consecutive quarter of sequential growth.
Total revenue for Q4 2025 was $35.2 million, a 2% increase quarter-over-quarter.
GAAP net income for Q4 2025 was $1.8 million, representing 5% of revenue.
Adjusted EBITDA for Q4 2025 was $8.7 million, representing 25% of revenue.
Cash flow from operating activities increased 13% year-over-year to $7.2 million, representing 20% of revenue.
Forward Guidance
The company anticipates continued strong execution and momentum across its portfolio, leveraging its mission to turn human understanding into measurable action. NRC Health is committed to helping partners elevate experiences for the people they serve amidst healthcare complexity.
Positive Outlook
- Strong foundation for continued execution.
- Building momentum across the portfolio.
- Mission-driven approach to human understanding in healthcare.
- Focus on helping partners elevate patient experiences.
- Anticipated growth in Total Recurring Contract Value.
Challenges Ahead
- Unprecedented complexity in the healthcare landscape.
- Potential risks and uncertainties as set forth in the Risk Factors section of the Annual Report on Form 10-K.
- No specific negative financial guidance provided in the press release.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...